Advanced models incorporating C-reactive protein, D-dimer levels, and hypoxia markers could enhance the prediction of secondary complications such as post-stroke edema, hemorrhagic transformation, or delayed neurological deterioration. The gene discussed is CRP; the disease is stroke disorder.